Analysts Set Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) PT at $14.90
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Get Free Report) has received an average rating of “Moderate Buy” from the eight ratings firms that are covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and five have assigned a buy rating to the company. […]
Analysts Set PTC Inc. (NASDAQ:PTC) PT at $188.08
PTC Inc. (NASDAQ:PTC – Get Free Report) has received an average rating of “Moderate Buy” from the seventeen ratings firms that are presently covering the company, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, five have assigned a hold recommendation and eleven have given a buy recommendation to the company. The […]
Analysts Set Nkarta, Inc. (NASDAQ:NKTX) PT at $13.25
Nkarta, Inc. (NASDAQ:NKTX – Get Free Report) has received an average rating of “Moderate Buy” from the six brokerages that are presently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and four have issued a buy recommendation on the […]
Analysts Set DexCom, Inc. (NASDAQ:DXCM) PT at $85.18
DexCom, Inc. (NASDAQ:DXCM – Get Free Report) has received an average recommendation of “Moderate Buy” from the twenty-five research firms that are covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, five have issued a hold rating, seventeen have given a buy rating and two have assigned […]
Analysts Set MediWound Ltd. (NASDAQ:MDWD) PT at $31.67
Shares of MediWound Ltd. (NASDAQ:MDWD – Get Free Report) have received a consensus rating of “Hold” from the five brokerages that are currently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, one has given a hold recommendation and three have given a buy recommendation to the company. […]
Analysts Set Bitfarms Ltd. (NASDAQ:BITF) PT at $4.04
Shares of Bitfarms Ltd. (NASDAQ:BITF – Get Free Report) have earned an average rating of “Moderate Buy” from the nine ratings firms that are currently covering the company, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and seven have assigned a buy recommendation to […]
last updated on 19 Mar 05:50